IP Library Granted Patent US 8,877,906
Granted Patent B2
US 8,877,906 · App. 13/608,385 · Granted Nov 4, 2014

Amphiphiles for protein solubilization and stabilization

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,877,906
App. No.
13/608,385
Granted
Nov 4, 2014
Kind
B2
Abstract

The invention provides amphiphiles for manipulating membrane proteins. The amphiphiles can feature carbohydrate-derived hydrophilic groups and branchpoints in the hydrophilic moiety and/or in a lipophilic moiety. Such amphiphiles are useful as detergents for solubilization and stabilization of membrane proteins, including photosynthetic protein superassemblies obtained from bacterial membranes.

Claims (40)

1. An amphiphilic compound of Formula VII:

wherein

Y is —CH 2 — or —NH(C 1 -C 4 alkyl)-;

Z is O or absent;

R 5 is H or a C 6 glycosyl residue; and

each R 6 is independently H or C 1 -C 6 alkyl.

2. The amphiphilic compound of claim 1 wherein Y is CH 2 or —NH(CH 2 —CH 2 )—.

3. The amphiphilic compound of claim 1 wherein Z is O.

4. The amphiphilic compound of claim 1 wherein R 5 is H.

5. The amphiphilic compound of claim 1 wherein R 5 is an O-linked glucose, mannose, galactose.

6. The amphiphilic compound of claim 1 wherein the compound is:

7. The amphiphilic compound of claim 1 wherein Z is absent.

8. The amphiphilic compound of claim 7 wherein Y is —CH 2 —.

9. The amphiphilic compound of claim 8 wherein R 5 is H.

10. The amphiphilic compound of claim 8 wherein R 5 is an O-linked glucose, mannose, galactose.

11. A method for solubilizing or stabilizing a membrane protein comprising contacting a protein in an aqueous environment with an effective amount of a compound of claim 1 , and optionally heating the protein and the compound, to provide the solubilized protein encapsulated in micelles of the compound.

12. An amphiphilic compound of Formula VIII:

wherein Y is —CH 2 —,

both R groups are C 1 -C 8 straight chain alkyl,

R 1 is phenyl,

—X—R 2 is direct bond-H, and

R 3 is H an O-linked C 6 glycosyl residue, an O-linked oligosaccharide comprising two or more glycosyl residues,or a C 1 -C 4 alkyl-(N,N-dimethyl)-oxide; and

R 4 is an O-linked C 6 glycosyl residue, an O-linked oligosaccharide comprising two or more glycosyl residues, or a C 1 -C 4 alkyl-(N,N-dimethyl)N-oxide provided that

one or both of R 3 and R 4 are O-linked glucose, mannose, galactose, maltose or sucrose residues or O-linked oligosaccharides comprising two or more glycosyl residues.

13. The amphiphilic compound of claim 12 wherein the compound is:

14. An amphiphilic compound of Formula VIII:

wherein

Y is C 1 -C 4 alkylene, —NH(C 1 -C 4 alkyl)-, or a direct bond;

Z is O or absent, provided that when Y is a direct bond, Z is O;

each R is independently C 1 -C 16 straight or branched alkyl C 3 -C 8 cycloalkyl, C 3 -C 8 cycloalkenyl, phenyl, biphenyl, or C 3 -C 8 cycloalkyl, C 3-C 8 cycloalkenyl, phenyl, or biphenyl substituted with one, two, or three C 1 -C 6 straight or branched alkyl groups; or

the two R groups together with the carbon to which they are attached form a C 3 -C 8 cycloalkyl, a C 3 -C 8 cycloalkenyl, or an adamanttyl ring;

R 1 is H, C 1 -C 16 straight or branched alkyl,C 3 -C 8 cycloalkyl, C 3 -C 8 cycloalkenyl, phenyl, biphenyl, halophenyol, p-tolyl, adamantyl or C 3 -C 8 cycloalkyl C 3 -C 8 cycloalkenyl, phenyl, biphenyl, halophenyl, p-tolyl, or adamantyl substituted with one two or three C 1 -C 6 straight or branched alkyl groups; or

R, R, and R 1 together with the carbon to which they are attached form an adamantyl ring, optionally substituted with one, two, or three C 1 -C 6 straight or branched alkyl groups;

each X is independently CH 2 or a direct bond;

R 2 is H, an O-linked C 6 glycosyl residue, an O-linked oligosaccharide comprising two or more glycosyl residues, or a C 1 - 4 alkyl-(N,N-dimethyl)N-oxide;

R 3 is H, an O-linked C 6 glycosyl residue, O-linked oligosaccharide comprising two or more glycosyl residue, or a C 1 -C 4 alkyl -(N,N-dimethyl)N-oxide; and

R 4 is an O-linked C 6 gylcosyl residue an O-linked oligosaccharide comprising two or more gylcosyl residues, or a C 1-C 4 alkyl-(N,N-dimethyl)N-oxide; provided that

one or both of R 3 and R 4 are C 1 -C 4 alkyl-(N,N-dimethyl)N-oxide.

15. The amphiphilic compound of claim 14 wherein the compound is:

16. A method for solubilizing or stabilizing a membrane protein comprising contacting a protein in an aqueous environment with an effective amount of a compound of claim 12 , and optionally heating the protein and the compound, to provide the solubilized protein encapsulated in micelles of the compound.

Assignments (5)
CONFIRMATORY LICENSE Recorded Oct 13, 2021
From: UNIVERSITY OF WISCONSIN-MADISON
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 057790/0878 →
RELEASE OF SECURITY INTEREST Recorded Jul 17, 2017
From: OPUS BANK
To: ANATRACE PRODUCTS, LLC; EDGE BIOSYSTEMS, INC.
Reel/Frame 043026/0351 →
RELEASE OF SECURITY INTEREST Recorded Jul 17, 2017
From: FIDUS MEZZANINE CAPITAL, L.P.
To: ANATRACE PRODUCTS, LLC; EDGE BIOSYSTEMS, INC.
Reel/Frame 043026/0361 →
SECURITY INTEREST Recorded Dec 30, 2015
From: EDGE BIOSYSTEMS, INC.; ANATRACE PRODUCTS, LLC
To: FIDUS MEZZANINE CAPITAL, L.P.
Reel/Frame 037380/0659 →
PATENT SECURITY AGREEMENT Recorded Dec 29, 2015
From: EDGE BIOSYSTEMS, INC.; ANATRACE PRODUCTS, LLC
To: OPUS BANK
Reel/Frame 037396/0638 →